Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Xu, Meifeng ^a   Wang, Yigang ^a   Hirai, Kyoji ^a   Ayub, Ahmar ^a   Ashraf, Muhammad ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anoxia reoxygenation; Cytochrome c; Neonatal rat myocytes

Indexed keywords

ATRACTYLOSIDE; CYCLOSPORIN; CYTOCHROME C; LACTATE DEHYDROGENASE;

ANIMAL CELL; ANOXIA; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; ENZYME RELEASE; MITOCHONDRION; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; REPERFUSION INJURY;

EID: 0034996372     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.2.h899     Document Type: Article

References (42)

1. 2+ paradox injury in rat heart: role of adenosine. Circ Res 74: 360-367, 1994.
2. Baker CS, Rimoldi O, Camici PG, Barnes E, Chacon MR, Huehns TY, Haskard DO, Polak JM, and Hall RJ. Repetitive myocardial stunning in pigs is associated with the increased expression of inducible and constitutive nitric oxide synthases. Cardiovasc Res 43: 685-697, 1999.
3. Bialik S, Geenen DL, Sasson IE, Valentino KL, Fritz LC, and Kitsis RN. The caspase family of cysteine proteases mediates cardiac myocyte apoptosis during myocardial infarction (Abstract). Circulation 96, Suppl I: I-552, 1997.
4. Cain BS, Meldrum DR, Meng X, Shames BD, Banerjee A, and Harken AH. Calcium preconditioning in human myocardium. Ann Thorac Surg 65: 1065-1070, 1998.
5. Cook SA, Sugden PH, and Clerk A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85: 940-949, 1999.
6. 2+ overload. Eur J Biochem 178: 489-501, 1988.
7. 2+, intercellular electrical coupling, and mechanical activity in ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade. Circ Res 79: 237-246, 1996.
8. Duchen MR, McGuinness O, Brown LA, and Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 27: 1790-1794, 1993.
9. Duranteau J, Chandel NS, Kulisz A, Shao Z, and Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273: 11619-11624, 1998.
10. Fleckenstein A, Frey M, and Fleckenstein-Grun G. Consequences of uncontrolled calcium entry and its prevention with calcium antagonists. Eur Heart J 4, Suppl H: 43-50, 1983.
11. Griffiths EJ and Halestrap AP. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matrix peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppressive and toxic effects of cyclosporin. Biochem J 274: 611-614, 1991.
12. Halestrap AP, Connern CP, Griffiths EJ, and Kerr PM. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/ reperfusion injury. Mol Cell Biochem 174: 167-172, 1997.
13. + channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol 275: H1567-H1576, 1998.
14. Ismaili A, Philpott DJ, Dytoc MT, Soni R, Ratnam S, and Sherman PM. α-Actinin accumulation in epithelial cells infected with attaching and effacing gastrointestinal pathogens. J Infect Dis 172: 1393-1396, 1995.
15. Jennings RB, Schaper J, Hill ML, Steenbergen C Jr, and Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 56: 262-278, 1985.
16. Kroemer G, Dallaporta B, and Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60: 619-642, 1998.
17. Lemasters JJ, Nieminen AL, Qian T, Trost LC, and Herman B. The mitochondrial permeability transition in toxic, hypoxic and reperfusion injury. Mol Cell Biochem 174: 159-165, 1997.
18. Liu GS, Ravens U, Sadony V, Vandeplassche G, and Borgers M. Functional and structural impairment in human, rat and guinea-pig atrial muscle in response to in vitro calcium overload: a cytochemical study on cellular calcium distribution. J Mol Cell Cardiol 23: 795-805, 1991.
19. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, and Das DK. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233-237, 1996.
20. Maulik N, Yoshida T, Zu YL, Sato M, Banerjee A, and Das DK. Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol Heart Circ Physiol 275: H1857-H1864, 1998.
21. Meldrum DR. Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning. J Surg Res 73: 1-13, 1997.
22. 2+ as a mediator of ischemic preconditioning. Circ Res 80: 790-799, 1997.
23. Miyawaki H, Zhou X, and Ashraf M. Calcium preconditioning elicits strong protection against ischemic injury via protein kinase C signaling pathway. Circ Res 79: 137-146, 1996.
24. i in perfused rabbit hearts. Circ Res 69: 1525-1537, 1991.
25. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
26. Pastorino JG, Chen ST, Tafani M, Snyder JW, and Farber JL. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 273: 7770-7775, 1998.
27. Pierce GN and Czubryt MP. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol 27: 53-63, 1995.
28. Piot CA, Martini JF, Bui SK, and Wolfe CL. Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly (ADP-ribose) polymerase in rat hearts in vivo. Cardiovasc Res 44: 536-542, 1999.
29. Przyklenk K, Hata K, and Kloner RA. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation 96: 1305-1312, 1997.
30. Roberg K, Johansson U, and Ollinger K. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic Biol Med 27: 1228-1237, 1999.
31. Schultz JE, Hsu AK, Barbieri JT, Li PL, and Gross GJ. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol Heart Circ Physiol 275: H495-H500, 1998.
32. Smith GB, Stefenelli T, Wu ST, Wilkman-Coffelt J, Parmley WW, and Zaugg CE. Rapid adaptation of myocardial calcium homeostasis to short episodes of ischemia in isolated rat hearts. Am Heart J 131: 1106-1112, 1996.
33. Steenbergen C, Fralix TA, and Murphy E. Role of increased cytosolic free calcium concentration in myocardial ischemic injury. Basic Res Cardiol 88: 456-470, 1993.
34. Steenbergen C, Murphy E, Levy L, and London RE. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 60: 700-707, 1987.
35. ATP channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 85: 1146-1153, 1999.
36. 2+ overload injury in rat myocardium. Circ Res 84: 1156-1165, 1999.
37. + channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res 85: 731-741, 1999.
38. Xu M, Tang PL, Qian ZM, and Ashraf M. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci. In press.
39. Yang JC and Cortopassi GA. dATP causes specific release of cytochrome C from mitochondria. Biochem Biophys Res Commun 250: 454-457, 1998.
40. Yao Z, Tong J, Tan X, Li C, Shao Z, Kim WC, Vanden Hoek TL, Becker L, Head CA, and Schumacker PT. Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol Heart Circ Physiol 277: H2504-H2509, 1999.
41. Ytrehus K, Liu Y, and Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol Heart Circ Physiol 266: H1145-H1152, 1994.
42. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, and Kroemer G. Mitochondrial control of nuclear apoptosis. J Exp Med 183: 1533-1544, 1996.